The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMPLIPHI BIOSCIENCES CORP | COM NEW | 03211P202 | 1,580 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
AMPLIPHI BIOSCIENCES CORP | COM NEW | 03211P202 | 2,997 | 758,788 | SH | DFND | 758,788 | 0 | 0 | ||
CRESTWOOD MIDSTREAM PARTNERS | UNIT LTD PARTNER | 226378107 | 1,759 | 284,620 | SH | SOLE | 284,620 | 0 | 0 | ||
ENERGY TRANSFER PRTNRS L P | UNIT LTD PARTN | 29273R109 | 3,188 | 77,635 | SH | SOLE | 77,635 | 0 | 0 | ||
ENERGY TRANSFER EQUITY L P | COM UT LTD PTN | 29273V100 | 15,657 | 752,400 | SH | SOLE | 752,400 | 0 | 0 | ||
ENTERPRISE PRODS PARTNERS L | COM | 293792107 | 25,792 | 1,035,834 | SH | SOLE | 1,035,834 | 0 | 0 | ||
FIBROCELL SCIENCE INC | COM NEW | 315721209 | 39,346 | 10,219,631 | SH | SOLE | 10,219,631 | 0 | 0 | ||
FIBROCELL SCIENCE INC | COM NEW | 315721209 | 24,643 | 6,400,783 | SH | DFND | 6,400,783 | 0 | 0 | ||
GENESIS ENERGY L P | UNIT LTD PARTN | 371927104 | 8,320 | 217,000 | SH | SOLE | 217,000 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 266,308 | 19,829,337 | SH | SOLE | 19,829,337 | 0 | 0 | ||
HISTOGENICS CORP | COM | 43358V109 | 10,708 | 2,690,570 | SH | DFND | 2,690,570 | 0 | 0 | ||
INTREXON CORP | COM | 46122T102 | 1,962,845 | 61,724,682 | SH | SOLE | 61,724,682 | 0 | 0 | ||
MARTIN MIDSTREAM PRTNRS L P | UNIT L P INT | 573331105 | 3,460 | 141,800 | SH | SOLE | 141,800 | 0 | 0 | ||
NUSTAR ENERGY LP | UNIT COM | 67058H102 | 5,222 | 116,500 | SH | SOLE | 116,500 | 0 | 0 | ||
ORAGENICS INC | COM NEW | 684023203 | 1,641 | 1,000,555 | SH | SOLE | 1,000,555 | 0 | 0 | ||
ORAGENICS INC | COM NEW | 684023203 | 14,495 | 8,838,666 | SH | DFND | 8,838,666 | 0 | 0 | ||
OVASCIENCE INC | COM | 69014Q101 | 849 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
OVASCIENCE INC | COM | 69014Q101 | 2,320 | 273,224 | SH | DFND | 273,224 | 0 | 0 | ||
SYNTHETIC BIOLOGICS INC | COM | 87164U102 | 21,822 | 9,613,268 | SH | DFND | 9,613,268 | 0 | 0 | ||
SYNTHETIC BIOLOGICS INC | COM | 87164U102 | 8,229 | 3,625,000 | SH | SOLE | 3,625,000 | 0 | 0 | ||
TC PIPELINES LP | UT COM LTD PRT | 87233Q108 | 4,618 | 97,000 | SH | SOLE | 97,000 | 0 | 0 | ||
TRANSGENOMIC INC | COM NEW | 89365K305 | 709 | 770,490 | SH | SOLE | 770,490 | 0 | 0 | ||
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 87,088 | 9,665,742 | SH | SOLE | 9,665,742 | 0 | 0 |